Learn More

Insights

Colorado Natural Medicine Advisory Bulletin #3: August 2023

By Joshua Kappel, Jeff Fitzgerald, Psychedelic Alpha
Sep 7, 2023

Colorado Natural Medicine Advisory Bulletins provide updates on the implementation of Colorado's legal psychedelics program, the Natural Medicine Health Act. Bulletin #3 focuses on updates from the August subcommittee meetings and the full meeting of the Natural Medicine Advisory Board. In addition, the Department of Revenue will hold NMHA listening sessions throughout September.

Maryland Cannabis Administration Releases Social Equity Verification Tool in Preparation for Cannabis Business Licensing

By Yolanda Clarke, Meg Nash
Sep 1, 2023

The Maryland Cannabis Administration and its Office of Social Equity took another step toward the first round of adult-use social equity licensing in the state with the announcement that their social equity verification portal will go live on September 8. This first round of adult-use licensing will be for standard or micro grower, processor, and dispensary license types. Only social equity applicants are eligible to take part in this first round and to qualify, you must first be officially verified as a social equity applicant.

US Officially Recognizes Medical Use and Safety of Cannabis: The Top 6 Things to Know About Schedule III and the Process Ahead

By Shawn Hauser
Aug 31, 2023

The federal government formally acknowledged the medical use and low potential of abuse for cannabis, with the US Department of Health and Human Services recommending that cannabis be rescheduled to Schedule III under the Controlled Substances Act. While placement in Schedule III still criminalizes commercial cannabis activity at the federal level, it is a significant step on the path to ending prohibition. This rescheduling would eliminate the application of 280E tax penalties, reduce the level of criminal liability for cannabis-related activity, reduce barriers to research, legitimize the industry through gaining credibility and engagement by physicians and the medical community, and support a growing industry for the American economy.